So reads the headline in the Globe today and it turns out it’s a column by Margaret Wente.
Certainly, ignorance can be bliss, but in that case, should you really be writing columns? And parts of the argumentation are hogwash, too. Pharmaceutical companies apparently find gaining over the counter approval too costly. Really? Come on. It would make the drug more available and that means money–for said pharmaceutical companies. Anyway, no need to type more; I’ve already written a column in response.by